Publications by authors named "Jean Louis Lacaze"

Claim this Profile
I
Investigating the clinical impact of dose-banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study.
Florent Puisset, Félicien Le Louedec, Florence Dalenc, Lorène Verguet, Eleonora De Maio, Jean Louis Lacaze

Br J Clin Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to 'Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes' [The Breast (2023) 102-109].
Gauthier Glemarec, Jean-Louis Lacaze, Bastien Cabarrou, Richard Aziza, Eva Jouve

Breast· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution.
Jean-Louis Lacaze, Ciprian Chira, Gauthier Glemarec, Nils Monselet, Thibaut Cassou-Mounat

Breast Cancer Res Treat· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes.
Gauthier Glemarec, Jean-Louis Lacaze, Bastien Cabarrou, Richard Aziza, Eva Jouve

Breast· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment time interval in breast cancer: A population-based study on the impact of type and number of cancer centres attended.
Amalia Martinez, Laetitia Daubisse-Marliac, Jean-Louis Lacaze, Elvire Pons-Tostivint, Eric Bauvin

Eur J Cancer Care (Engl)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, biology and epidemiology of oligometastatic breast cancer.
Jean-Louis Lacaze, Richard Aziza, Ciprian Chira, Eleonora De Maio, Françoise Izar

Breast· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral mucosal changes induced by adjuvant endocrine therapies in breast cancer patients: clinical aspects and proposal for management.
Caroline de Bataille, Marie Castellan, Carole Massabeau, Eva Jouve, Jean-Louis Lacaze

Support Care Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.
William Jacot, Florence Dalenc, Evelyne Lopez-Crapez, Leonor Chaltiel, Anna Durigova, Jean-Louis Lacaze

Breast Cancer Res Treat· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Observational study of outpatient unit duration of stay depending on the route of administration (intravenous vs subcutaneous) for a targeted therapy].
Frédéric Despiau, Yann Zagala, Jean-Pierre Delord, Marion Montastruc, Jean-Louis Lacaze

Bull Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome.
Vincent Sibaud, Florence Dalenc, Christine Chevreau, Henri Roché, Jean-Pierre Delord, Jean-Louis Lacaze

Oncologist· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis